Phosphorothioate Modification

Phosphorothioate Modification is a chemical nucleic acid modification in which one of the non-bridging oxygen atoms in the phosphate backbone is substituted with a sulfur atom, thereby conferring nuclease resistance and enhanced binding affinity.

653

Publications

37.8K

Citations

2.6K

Authors

665

Institutions

Publications per year

2017–2026

123

Authors

2.6K

  1. ST
    Stanley T. Crooke

    Ionis Pharmaceuticals (United States), United States

    24 publications · 2.1K citations

    21

    h-index

  2. XL
    Xue‐hai Liang

    Ionis Pharmaceuticals (United States), United States

    21 publications · 1.8K citations

    19

    h-index

  3. PP
    Punit P. Seth

    Ionis Pharmaceuticals (United States), United States

    18 publications · 1.3K citations

    17

    h-index

  4. ZD
    Zixin Deng

    Shanghai Jiao Tong University, China

    19 publications · 916 citations

    16

    h-index

  5. FE
    Fritz Eckstein

    Max Planck Institute of Experimental Medicine, Germany

    15 publications · 2.9K citations

    15

    h-index

1–5 of 2.6K

Venues

  1. Nucleic Acids Research

    114 publications · 11.1K citations

    58

    h-index

  2. Biochemistry

    28 publications · 1.9K citations

    22

    h-index

  3. Journal of Biological Chemistry

    JBC · 23 publications · 2.3K citations

    19

    h-index

  4. Journal of the American Chemical Society

    JACS · 20 publications · 1.3K citations

    19

    h-index

  5. Proceedings of the National Academy of Sciences

    PNAS · 18 publications · 2K citations

    17

    h-index

1–5